Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19

Purpose of the studyThe aim of this study was to investigate the relationship of B cell-mediated immunity with disease severity and mortality in patients with COVID-19.Study designIn this retrospective cohort and single-centre study, 208 patients with laboratory-confirmed COVID-19 were recruited. A...

Full description

Saved in:
Bibliographic Details
Published in:Postgraduate medical journal Vol. 98; no. 1164; pp. 765 - 771
Main Authors: Çölkesen, Fatih, Kepenek Kurt, Esma, Vatansev, Hülya, Korkmaz, Celalettin, Çölkesen, Fatma, Yücel, Fatih, Yıldız, Eray, Evcen, Recep, Aykan, Filiz Sadi, Kılınç, Mehmet, Aytekin, Gökhan, Feyzioğlu, Bahadır, Doğan, Metin, Arslan, Şevket, Teke, Turgut, Keleş, Sevgi, Reisli, İsmail
Format: Journal Article
Language:English
Published: England The Fellowship of Postgraduate Medicine 01-10-2022
Oxford University Press
BMJ Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of the studyThe aim of this study was to investigate the relationship of B cell-mediated immunity with disease severity and mortality in patients with COVID-19.Study designIn this retrospective cohort and single-centre study, 208 patients with laboratory-confirmed COVID-19 were recruited. A COVID-19 severity score, ranging from 0 to 10, was used to evaluate associations between various factors. Serum immunoglobulin levels and the number of cells in B lymphocyte subsets were measured and their association with disease severity and mortality in patients with COVID-19 examined.ResultsThe median age of the patients was 50 (35–63) years and 88 (42%) were female. The number of deceased patients was 17. The median COVID-19 severity score was 8 (6–8) in deceased patients and 1 (0–2) in survivors. Deceased patients had significantly lower levels of total B lymphocytes, naive B cells, switched memory B cells, and serum IgA, IgG, IgG1 and IgG2 than recovered patients (all p<0.05). In addition, a significant negative correlation was found between the number of these parameters and COVID-19 severity scores. Decrease in the number of total B cells and switched memory B cells as well as lower serum IgA, IgG and IgG1 levels were independent risk factors for mortality in patients with COVID-19.ConclusionIn the present study, the prognosis of patients with COVID-19 was shown to be associated with the B cell subset and serum immunoglobulin levels.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0032-5473
1469-0756
DOI:10.1136/postgradmedj-2021-140540